[Metabolic-inhibition effect of vasopressin].
D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001833:Body Temperature Regulation / Q000187:drug effects*; D050260:Carbohydrate Metabolism; D002245:Carbon Dioxide / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood; D008239:Lysine / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010121:Oxytocin / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012119:Respiration / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology*
D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D011506:Proteins; D014667:Vasopressins; D002245:Carbon Dioxide; D010121:Oxytocin; D001120:Arginine; D008239:Lysine; D009638:Norepinephrine